alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 31.1
 
 CERTIFICATIONS PURSUANT TO
 SECTION 302 OF
 THE SARBANES-OXLEY ACT OF 2002
 
 I, James S. Osterman, certify that:
  1.
I have reviewed this quarterly report on Form 10-Q of Blount International, Inc.;  2.
Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;  3.
Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;  4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and we have:  a.
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;  b.
evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and  c.
disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and  5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors:  a.
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are   
 reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
  b.
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls.  
 Date: November 12, 2004
 
 /s/ James S. Osterman
 James S. Osterman
 President and
 Chief Executive Officer
I 

114TH CONGRESS 

1ST SESSION H. R. 233 

To allow reviews of certain families’ incomes every 3 years for purposes 

of determining eligibility for certain Federal assisted housing programs. 

IN THE HOUSE OF REPRESENTATIVES 

JANUARY 8, 2015 

Mr. PERLMUTTER (for himself and Mr. STIVERS) introduced the following bill; 

which was referred to the Committee on Financial Services 

A BILL 

To allow reviews of certain families’ incomes every 3 years 

for purposes of determining eligibility for certain Federal 

assisted housing programs. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Tenant Income 

5 Verification Relief Act of 2015’’. 

6 SEC. 2. REVIEWS OF FAMILY INCOMES. 

7 (a) IN GENERAL.—The second sentence of paragraph 

8 (1) of section 3(a) of the United States Housing Act of 

9 1937 (42 U.S.C. 1437a(a)(1)) is amended by inserting be10 fore the period at the end the following: ‘‘; except that, 


emcdonald on DSK67QTVN1PROD with BILLS
2 

•HR 233 IH

1 in the case of any family with a fixed income, as defined 

2 by the Secretary, after the initial review of the family’s 

3 income, the public housing agency or owner shall not be 

4 required to conduct a review of the family’s income for 

5 any year for which such family certifies, in accordance 

6 with such requirements as the Secretary shall establish, 

7 which shall include policies to adjust for inflation-based 

8 income changes, that 90 percent or more of the income 

9 of the family consists of fixed income, and that the sources 

10 of such income have not changed since the previous year, 

11 except that the public housing agency or owner shall con12 duct a review of each such family’s income not less than 

13 once every 3 years’’. 

14 (b) HOUSING CHOICE VOUCHER PROGRAM.—Sub15 paragraph (A) of section 8(o)(5) of the United States 

16 Housing Act of 1937 (42 U.S.C. 1437f(o)(5)(A)) is 

17 amended by striking ‘‘not less than annually’’ and insert18 ing ‘‘as required by section 3(a)(1) of this Act’’. 

Æ 


emcdonald on DSK67QTVN1PROD with BILLS
COURT OF APPEALS OF VIRGINIA

Present: Judges Fitzpatrick, Overton and Senior Judge Duff Argued at Alexandria, Virginia

THOMAS J. CARROLL, JR. MEMORANDUM OPINION * BY v. Record No. 1089-96-4 JUDGE CHARLES H. DUFF JUNE 24, 1997 COMMONWEALTH OF VIRGINIA

FROM THE CIRCUIT COURT OF FAUQUIER COUNTY Thomas D. Horne, Judge Jeffrey B. Rice for appellant. Marla Graff Decker, Assistant Attorney General (James S. Gilmore, III, Attorney General, on brief), for appellee.

Appellant contends that the trial court erred in denying his motion to suppress. He alleges that he was unlawfully stopped at a Virginia State Police traffic checking detail which lacked constitutionally adequate safeguards. Thus, he alleges, evidence of his intoxication was unlawfully obtained and should have been suppressed. Appellant bears the burden of submitting a record sufficient for this Court's consideration of the issues presented. See

Smith v. Commonwealth , 16 Va. App. 630, 635, 432 S.E.2d 2, 6 (1993). While appellant included a transcript of the suppression hearing in the record on appeal, he failed to include a transcript of the trial or a written statement of facts

* Pursuant to Code § 17-116.010 this opinion is not designated for publication.2 reflecting what occurred at trial. This Court, in reviewing a trial court's ruling on a motion to suppress, views the evidence in the light most favorable to the prevailing party, and reviews the "evidence adduced at both the trial and the suppression hearing." Greene v. Commonwealth , 17 Va. App. 606, 608, 440 S.E.2d 138, 139 (1994). See Spivey v.

Commonwealth , 23 Va. App. 715, 721, 479 S.E.2d 543, 546 (1997). This Court retains jurisdiction over a case in which portions of the record are not properly filed and may decide an issue where the missing portions are not indispensable. See

Williams v. Commonwealth , 7 Va. App. 516, 519, 375 S.E.2d 364, 366 (1988) ( en banc ); Turner v. Commonwealth , 2 Va. App. 96, 99, 341 S.E.2d 400, 402 (1986). We hold that in this case, however, a transcript or written statement of facts of the trial is indispensable to a proper review of the trial court's denial of the suppression motion. Accordingly, this case is dismissed.

Dismissed

.
# C_2022081EN.01011201.xml

| 18.2.2022 | EN | Official Journal of the European Union | C 81/112 |
| --- | --- | --- | --- |

18.2.2022

EN

Official Journal of the European Union

C 81/112

---

P9_TA(2021)0304

EU/Thailand Agreement: modification of concessions on all the tariff-rate quotas included in the EU Schedule CLXXV as a consequence of the United Kingdom's withdrawal from the European Union ***

European Parliament legislative resolution of 23 June 2021 on the draft Council decision on the conclusion of the agreement between the European Union and the Kingdom of Thailand pursuant to Article XXVIII of the General Agreement on Tariffs and Trade (GATT) 1994 relating to the modification of concessions on all the tariff-rate quotas included in the EU Schedule CLXXV as a consequence of the United Kingdom's withdrawal from the European Union (05444/2021 — C9-0171/2021 — 2021/0003(NLE))

(Consent)

(2022/C 81/14)

The European Parliament,

| — | having regard to the draft Council decision (05444/2021), |
| --- | --- |

—

having regard to the draft Council decision (05444/2021),

| — | having regard to the draft agreement between the European Union and the Kingdom of Thailand pursuant to Article XXVIII of the General Agreement on Tariffs and Trade (GATT) 1994 relating to the modification of concessions on all the tariff-rate quotas included in the EU Schedule CLXXV as a consequence of the United Kingdom's withdrawal from the European Union (05445/2021), |
| --- | --- |

—

having regard to the draft agreement between the European Union and the Kingdom of Thailand pursuant to Article XXVIII of the General Agreement on Tariffs and Trade (GATT) 1994 relating to the modification of concessions on all the tariff-rate quotas included in the EU Schedule CLXXV as a consequence of the United Kingdom's withdrawal from the European Union (05445/2021),

| — | having regard to the request for consent submitted by the Council in accordance with Article 207(4), first subparagraph, and Article 218(6), second subparagraph, point (a) (v), of the Treaty on the Functioning of the European Union (C9-0171/2021), |
| --- | --- |

—

having regard to the request for consent submitted by the Council in accordance with Article 207(4), first subparagraph, and Article 218(6), second subparagraph, point (a) (v), of the Treaty on the Functioning of the European Union (C9-0171/2021),

| — | having regard to Rule 105(1) and (4), and Rule 114(7) of its Rules of Procedure, |
| --- | --- |

—

having regard to Rule 105(1) and (4), and Rule 114(7) of its Rules of Procedure,

| — | having regard to the recommendation of the Committee on International Trade (A9-0180/2021), |
| --- | --- |

—

having regard to the recommendation of the Committee on International Trade (A9-0180/2021),

1.

Gives its consent to the conclusion of the agreement;

2.

Instructs its President to forward its position to the Council, the Commission and the governments and parliaments of the Member States and of the Kingdom of Thailand.

---
IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 11-50782

Conference Calendar

UNITED STATES OF AMERICA,

Plaintiff-Appellee

v.

BENJAMIN WHIPPLE, JR., also known as Benjamin Whipple,

Defendant-Appellant

Appeal from the United States District Court

for the Western District of Texas

USDC No. 3:08-CR-2396-1

Before DAVIS, STEWART, and PRADO, Circuit Judges.

PER CURIAM:*

Appealing the judgment in a criminal case, Benjamin Whipple, Jr., raises

an argument that he concedes is foreclosed by United States v. Slaughter, 238

F.3d 580 (5th Cir. 2000), which rejected a challenge based on the reasoning of

Apprendi v. New Jersey, 530 U.S. 466 (2000), to the constitutionality of 21 U.S.C.

§ 841(b). The Government’s motion for summary affirmance is GRANTED, its

alternative motion for an extension of time to file a brief is DENIED, and the

judgment of the district court is AFFIRMED.

United States Court of Appeals

Fifth Circuit

F I L E D

June 19, 2012

Lyle W. Cayce

Clerk

Pursuant to 5TH CIR. R. 47.5, the court has determined that this opinion should not *

be published and is not precedent except under the limited circumstances set forth in 5TH CIR.

R. 47.5.4.

Case: 11-50782 Document: 00511891172 Page: 1 Date Filed: 06/19/2012
```

[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2428 Introduced in House (IH)]

114th CONGRESS
  1st Session
                                H. R. 2428

   To amend the Federal Food, Drug, and Cosmetic Act with respect to 
              humanitarian device exemption applications.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                              May 19, 2015

 Mr. Shimkus introduced the following bill; which was referred to the 
                    Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL

 
   To amend the Federal Food, Drug, and Cosmetic Act with respect to 
              humanitarian device exemption applications.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. HUMANITARIAN DEVICE EXEMPTION APPLICATION.

    (a) In General.--Section 520(m) of the Federal Food, Drug, and 
Cosmetic Act (21 U.S.C. 360j) is amended--
            (1) in paragraph (1) by striking ``fewer than 4,000'' and 
        inserting ``not more than 8,000'';
            (2) in paragraph (2)(A) by striking ``fewer than 4,000'' 
        and inserting ``not more than 8,000''; and
            (3) in paragraph (6)(A)(ii), by striking ``4,000'' and 
        inserting ``8,000''.
    (b) Guidance Document on Probable Benefit.--Not later than 18 
months after the date of enactment of this Act, the Secretary of Health 
and Human Services, acting through the Commissioner of Food and Drugs, 
shall publish a draft guidance document that defines the criteria for 
establishing ``probable benefit'' as that term is used in section 
520(m)(2)(C) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
360j(m)(2)(C)).
                                 <all>
```
I 

114TH CONGRESS 

1ST SESSION H. R. 2436 

To amend the Public Health Service Act with respect to appropriate age 

groupings to be included in research studies involving human subjects. 

IN THE HOUSE OF REPRESENTATIVES 

MAY 19, 2015 

Mrs. BLACKBURN (for herself and Mrs. CAPPS) introduced the following bill; 

which was referred to the Committee on Energy and Commerce 

A BILL 

To amend the Public Health Service Act with respect to 

appropriate age groupings to be included in research 

studies involving human subjects. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. APPROPRIATE AGE GROUPINGS IN CLINICAL 

4 RESEARCH. 

5 (a) INPUT FROM EXPERTS.—Not later than 180 

6 days after the date of enactment of this Act, the Director 

7 of the National Institutes of Health shall convene a work8 shop of experts on pediatrics and experts on geriatrics to 

9 provide input on— 


emcdonald on DSK67QTVN1PROD with BILLS
2 

•HR 2436 IH

1 (1) appropriate age groupings to be included in 

2 research studies involving human subjects; and 

3 (2) acceptable scientific justifications for ex4 cluding participants from a range of age groups 

5 from human subjects research studies. 

6 (b) GUIDELINES.—Not later than 180 days after the 

7 conclusion of the workshop under subsection (a), the Di8 rector of the National Institutes of Health shall publish 

9 guidelines— 

10 (1) addressing the consideration of age as an 

11 inclusion variable in research involving human sub12 jects; and 

13 (2) identifying criteria for justifications for any 

14 age-related exclusions in such research. 

15 (c) PUBLIC AVAILABILITY OF FINDINGS AND CON16 CLUSIONS.—The Director of the National Institutes of 

17 Health shall— 

18 (1) make the findings and conclusion resulting 

19 from the workshop under subsection (a) available to 

20 the public on the website of the National Institutes 

21 of Health; and 

22 (2) not less than biennially, disclose to the pub23 lic on such website the number of children included 

24 in research that is conducted or supported by the 

25 National Institutes of Health, disaggregated by deVerDate Sep 11 2014 02:50 May 27, 2015 Jkt 049200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H2436.IH H2436

emcdonald on DSK67QTVN1PROD with BILLS
3 

•HR 2436 IH

1 velopmentally appropriate age group, race, and gen2 der. 

Æ 


emcdonald on DSK67QTVN1PROD with BILLS
JACKSON GULCH RESERVOIRLatitude: 37.402Longitude: -108.273Elevation: 7844

JACKSON GULCH RESERVOIR

Courtesy NRCS - Go to Sharkstooth Site Page...



Sharkstooth

Courtesy NRCS - Go to Columbus Basin Site Page...



Columbus Basin

Courtesy NRCS - Go to Mancos Site Page...



Mancos
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute on Minority Health and Health Disparities Special Emphasis Panel; Impact of Structural Racism and Discrimination on Minority Health and Health Disparities.                    

*Date:*                         November 15-17, 2021.                    

*Time:*                         10:00 a.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, Gateway Plaza, 7201 Wisconsin Avenue, Bethesda, MD 20817 (Virtual Meeting).                    

*Contact Person:*                         Karen Nieves-Lugo, M.P.H., Ph.D., Scientific Review Officer, Office of Extramural Research Activities, National Institute on Minority Health and Health Disparities, National Institutes of Health, Gateway Building, 7201 Wisconsin Avenue, Bethesda, MD 20892, (301) 480-4727,                         *karen.nieveslugo@nih.gov*.                    

Dated: September 17, 2021.

David W. Freeman,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2021-20583 Filed 9-22-21; 8:45 am]

BILLING CODE 4140-01-P
Listen

# Teacher and Professional Staff Shortages and Equity in Education in Nevada

January 24, 2024

On November 14, 2022, the Nevada Advisory Committee to the U.S. Commission on Civil Rights adopted a proposal to undertake a study of shortages of teachers and other education professionals in Nevada schools and equity in education. The focus of the Committee’s inquiry was to examine whether shortages of teachers and other education professionals create inequities in the areas of access, quality of teaching, student learning, and student discipline. In addition, the Committee examined whether long-term substitute teachers and education professionals have access to sufficient training. While other important topics may have surfaced throughout the Committee’s inquiry, matters that are outside the scope of this specific civil rights mandate are left for another discussion.

As part of this inquiry, the Committee heard testimony via videoconference on April 6, 2023; and April 13, 2023; and May 26, 2023. The following report results from a review of testimony at these meetings, combined with recorded testimony presented before the 2022-23 Nevada legislative session submitted during this timeframe. It begins with a brief background of the issues to be considered by the Committee. It then identifies primary findings as they emerged from this testimony. Finally, it makes recommendations for addressing related civil rights concerns. This report and the recommendations included within it were adopted by a quorum of Committee members present at a meeting on November 17, 2023.

Report

Press Release

Nevada

-  All Reports 
-  Annual Statutory Enforcement 
-  Briefing Reports 
-  Advisory Committees Reports 
-  Budget and Performance 
-  FOIA Reports 
-  Data Inventory Program 
-  Civil Rights Complaints 
-  Historical Publications 
-  Archives
Listen

# Ejecución reglamentaria anual

-  Todos los informes 
-  Ejecución reglamentaria anual
|   | 1. | The      Quarterly Report fully complies with the requirements of Section 13(a) or      15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d));      and |
|--------|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 2. | The      information contained in the Quarterly Report fairly presents, in all      material respects, the financial condition and results of operations of      the Company. |
|--------|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   |    /s/  Granger      Cobb |
|--------|----------------------------------------------------|
|   | Granger      Cobb                                  |
|   | Co-Chief      Executive Officer                    |
|   | November      10, 2008                             |
# C_2021121EN.01004701.xml

| 9.4.2021 | EN | Official Journal of the European Union | C 121/47 |
| -------- | -- | -------------------------------------- | -------- |

---

Withdrawal of notification of a concentration (Case M.9489 — Air Canada/Transat) (Text with EEA relevance) (2021/C 121/05) On 15 April 2020, the European Commission received notification ( 1 ) of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 2 ) (‘Merger Regulation’). On 25 Mai 2020, the Commission decided to initiate proceedings ( 3 ) under Article 6(1)(c) of the Merger Regulation. On 2 April 2021, the notifying party informed the Commission that it withdrew its notification and demonstrated that it abandoned the concentration. ( 1 )  OJ C 131, 22.04.2020, p. 23. ( 2 )  OJ L 24, 29.1.2004, p. 1. ( 3 )  OJ C 180, 29.05.2020, p. 1.

---